Camber Capital Management as of June 30, 2024
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 37 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 26.4 | $952M | 1.8M | 544.22 | |
| Zimmer Holdings (ZBH) | 5.8 | $209M | 1.9M | 108.53 | |
| Baxter International (BAX) | 5.1 | $184M | 5.5M | 33.45 | |
| Medtronic SHS (MDT) | 4.9 | $177M | 2.3M | 78.71 | |
| Universal Hlth Svcs CL B (UHS) | 4.9 | $176M | 950k | 184.93 | |
| Globus Med Cl A (GMED) | 4.7 | $171M | 2.5M | 68.49 | |
| Viatris (VTRS) | 4.4 | $160M | 15M | 10.63 | |
| Humana (HUM) | 4.1 | $150M | 400k | 373.65 | |
| Myriad Genetics (MYGN) | 3.7 | $135M | 5.5M | 24.46 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.4 | $123M | 1.2M | 106.73 | |
| Ptc Therapeutics I (PTCT) | 3.0 | $107M | 3.5M | 30.58 | |
| Brookdale Senior Living (BKD) | 2.9 | $106M | 16M | 6.83 | |
| GSK Sponsored Adr (GSK) | 2.9 | $103M | 2.7M | 38.50 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $91M | 1.1M | 82.33 | |
| Select Medical Holdings Corporation (SEM) | 2.5 | $89M | 2.6M | 35.06 | |
| CVS Caremark Corporation (CVS) | 2.5 | $89M | 1.5M | 59.06 | |
| Walgreen Boots Alliance (WBA) | 2.3 | $85M | 7.0M | 12.10 | |
| Pfizer Call Option (PFE) | 1.9 | $70M | 2.5M | 27.98 | |
| Qiagen Nv Shs New (QGEN) | 1.7 | $62M | 1.5M | 41.09 | |
| Zimvie (ZIMV) | 1.6 | $59M | 3.3M | 18.25 | |
| Denali Therapeutics (DNLI) | 1.3 | $46M | 2.0M | 23.22 | |
| Perrigo SHS (PRGO) | 1.1 | $39M | 1.5M | 25.68 | |
| Herbalife Com Shs (HLF) | 0.9 | $31M | 3.0M | 10.39 | |
| Argenx Se Sponsored Adr (ARGX) | 0.9 | $31M | 72k | 430.04 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $24M | 150k | 158.00 | |
| Brookdale Sr Living Unit 11/15/2025 (BKDT) | 0.6 | $23M | 250k | 92.99 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $19M | 915k | 20.24 | |
| OraSure Technologies (OSUR) | 0.5 | $18M | 4.3M | 4.26 | |
| Inogen (INGN) | 0.4 | $16M | 2.0M | 8.13 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.4 | $16M | 355k | 43.97 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $13M | 500k | 25.06 | |
| Replimune Group (REPL) | 0.3 | $12M | 1.4M | 9.00 | |
| Evolent Health Cl A (EVH) | 0.3 | $12M | 625k | 19.12 | |
| Theravance Biopharma (TBPH) | 0.2 | $8.5M | 1.0M | 8.48 | |
| The Beauty Health Company Com Cl A (SKIN) | 0.2 | $6.7M | 3.5M | 1.92 | |
| Curevac N V (CVAC) | 0.1 | $1.9M | 550k | 3.40 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.0 | $1.3M | 50k | 25.14 |
